Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 1-10 of 92

Page
per page
  1. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  2. MK-8776 (SCH-900776)
    A8477 MK-8776 (SCH-900776)
    Target: Chk
    Summary: Chk1 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥18.8 mg/mL
  3. Docetaxel
    A4394 Docetaxel
     3 Citation
    Summary: Microtubulin disassembly inhibitor
      ≥40.4 mg/mL
  4. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO
  5. MLN0905
    A8680 MLN0905
    Target: PLK
    Summary: Potent PLK1 inhibitor
      ≥24.35 mg/mL
  6. Thiazovivin
    A5506 Thiazovivin
    Target: ROCK
    Summary: ROCK inhibitor
      ≥15.55 mg/mL
  7. HMN-214
    A5413 HMN-214
    Summary: Plk inhibitor,broad-spectrum anti-tumor agent
      ≥21.2 mg/mL
  8. BS-181 HCl
    A5700 BS-181 HCl
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor,highly selective
      insoluble in H2O; ≥20.85 mg/mL
  9. Vincristine sulfate
    A1765 Vincristine sulfate
    Target: Microtubule/Tubulin
    Summary: Microtubule disrupter,antitumor agent
      ≥46.15 mg/mL
  10. GSK429286A
    A5611 GSK429286A
    Target: ROCK
    Summary: Selective ROCK1/ROCK2 inhibitor
      ≥21.6 mg/mL

Items 1-10 of 92

Page
per page